Format

Send to:

Choose Destination
See comment in PubMed Commons below
Trends Immunol. 2008 Jun;29(6):290-4. doi: 10.1016/j.it.2008.02.008. Epub 2008 Apr 25.

Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses.

Author information

  • 1Dipartimento di Medicina Interna e Centro di Eccellenza per lo Studio Delle Malattie Complesse e Multifattoriali, Università Tor Vergata, Rome 00133, Italy. Gi.Monteleone@Med.uniroma2.it <Gi.Monteleone@Med.uniroma2.it>

Abstract

Naïve T cells can commit to effector [T helper 1 (Th1), Th2 and Th17] or regulatory lineages. Skewing of responses toward inflammatory Th1, Th2 or Th17 pathways and away from regulatory T-cell pathways might be responsible for the initiation and progress of immune-mediated diseases. Based on recent data, we propose that interleukin-21 (IL-21), a cytokine produced by activated CD4+ T cells, induces the development of Th17 cells, blocks the differentiation of transforming growth factor-beta1-induced regulatory T cells and renders CD4+ T cells resistant to the suppressive effects of regulatory T cells, thereby playing a major role in pathogenic T-cell responses.

PMID:
18440864
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk